(Circulation. 2003;108:II-116.)
© 2003 American Heart Association, Inc.
Surgery for Valvular Heart Disease |
From the Department of Cardiovascular and Thoracic Surgery, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, and Laboratory of Cardiovascular Physiology and Biophysics, Research Institute of the Palo Alto Medical Foundation, Palo Alto, California
Correspondence to D. Craig Miller, M.D., Department of Cardiovascular and Thoracic Surgery, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, CA 94305-5247. Phone: 650-723-3826, Fax: 650-725-3846, E-mail: dcm{at}stanford.edu
| Abstract |
|---|
|
|
|---|
Methods and Results Twenty-four sheep underwent coronary snare and marker placement (annulus, papillary muscles, and anterior and posterior leaflets). After 8 days, cinefluoroscopy provided 3-dimensional marker data, and snare occlusion of obtuse marginal branches created inferior myocardial infarction, including the posterior papillary muscle. After 7 weeks, the 16 surviving animals were studied again and grouped by mitral regurgitation grade (
2+, n=10 versus
1+, n=6). End-systolic mitral annulus dimensions, components of papillary muscle and leaflet displacement, were calculated. After inferior myocardial infarction, total displacement of the posterior papillary muscle from the midseptal annulus ("saddle horn") was greater in CIMR(+) animals: 6.5±3.2 versus 3.1±2.7 (P=0.02), with the posterior papillary muscle moving more laterally (6.8±3.4 versus 2.5±3.5 mm, P=0.01). Increase in mitral annular septal-lateral diameter was greater in animals with CIMR (4.9±2.7 versus 2.3±2.0, P=0.02), and apical displacement of the posterior leaflet (PL) margin was also greater in the CIMR(+) group (1.7±1.0 versus 0.3±0.5, P=0.01).
Conclusions The CIMR(+) group had greater septal-lateral annular dilatation, lateral posterior papillary muscle displacement, and apical PL restriction, indicating that these associated geometric alterations may be important in the pathogenesis of CIMR. Treatment of CIMR should address both annular septal-lateral dilatation and lateral displacement of the posterior papillary muscle.
Key Words: mitral regurgitation ischemic mitral regurgitation mitral annuloplasty mitral valve repair myocardial ischemia ischemic heart disease
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
|
Experimental Protocol
After 8±2 days, each animal was taken to the cardiac catheterization laboratory, sedated with ketamine (14 mg/kg/h i.v. infusion) and diazepam (5 mg i.v. bolus as needed), intubated, mechanically ventilated, and maintained with inhalational isoflurane (12.5%). Transesophageal echocardiography and coronary angiography were performed, and baseline videofluoroscopic marker and hemodynamic data acquired.
After premedication with lidocaine (100 mg i.v.), bretylium (75 mg i.v.), and magnesium (3 g i.v.), the coronary artery snares were then tightened, and complete occlusion of the selected vessels verified by angiography. An epinephrine drip was titrated to maintain coronary perfusion pressure (aortic diastolic pressure minus left ventricular diastolic pressure) >60 mmHg. Ventricular arrhythmias were treated with lidocaine (50100 mg i.v.) and amiodarone (50150 mg i.v.), as needed. The animal was then stabilized and recovered. The animals were followed for clinical signs of heart failure (tachypnea, lethargy, and anorexia), and serial transthoracic echocardiography was used to detect left ventricular dilatation and MR.
After 7±1 weeks, the animals returned to the cardiac catheterization laboratory for recording of hemodynamic, transesophageal echocardiography (TEE), and marker data. MR was graded based on regurgitant jet extent and width as none (0), trace (+0.5), mild (+1), moderate (+2), moderate-severe (+3), or severe (+4) by an experienced echocardiographer (DL) using a 3 chamber view (roughly equivalent to the vertical plane in a human study).9
All of the animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (DHEW NIHG publication 85 to 23, revised 1985). This study was approved by the Stanford University Medical School Laboratory Research Animal Review committee and conducted according to Stanford University policy.
Data Acquisition
Images were acquired with the animal in the right lateral position with a biplane videofluoroscopy system (Philips Medical Systems, North America Company). Data from 2 radiographic views were digitized and merged to yield 3-dimensional coordinates for each of the radiopaque markers every 16.7 ms using custom-designed software.10 Ascending aortic pressure, LV pressure, and ECG voltage signals were digitized and recorded simultaneously during marker data acquisition.
Data Analysis
Animal Grouping
Of the 24 animals that underwent coronary occlusion, 8 died acutely. The remaining 16 animals were divided into 2 groups on the basis of severity of MR at the time of the second study: Six did not develop significant MR (MR
1; "CIMR[-]" group), and 10 developed chronic ischemic MR (MR
2; "CIMR[+]" group).
Hemodynamics and Cardiac Cycle Timing
Three consecutive steady state beats before infarction were averaged and defined as "baseline" data for each animal. Similarly, at the follow-up study 3 beats were averaged and termed "chronic" data. During each cardiac cycle, end-systole was defined as the time of the videofluoroscopic frame containing the point of peak negative rate of left ventricular pressure fall (-dP/dt), and end-diastole as the videofluoroscopic frame containing the peak of the ECG R-wave. Instantaneous left ventricular volume was calculated from the positions of the epicardial LV markers and annular markers using a space-filling multiple tetrahedral volume method for each frame, ie, every 16.7 ms.11 Although myocardial volume is included in calculation of left ventricular volume, relative changes in left ventricular chamber size are accurately reflected.11
Papillary Muscle Geometry
End-systolic papillary muscle positions were determined using a reference system (Figure 1) defined by the least-squares best-fit plane of the annular markers, with the origin at the projection of the mid-septal annulus ("fibrosa" or saddle horn) marker (0') on this plane, positive lateral axis (L) in the annular plane passing through the mid-lateral annulus marker (#4), positive posterior axis (P) in the annular plane directed toward the right fibrous trigone, and positive apical axis (A) normal to the annular plane and directed toward the left ventricular apex. The total end-systolic papillary tip displacements between the baseline and chronic conditions were resolved into their lateral, posterior, and apical components (L, P, and A, respectively).
Mitral Leaflet Geometry
End-systolic anterior and posterior leaflet edge positions were calculated as the distance from the leaflet edge markers to the annular plane, with end-systolic leaflet displacements being the change in this distance between baseline and chronic studies. Leaflet displacements between baseline and chronic conditions were also resolved into their lateral, posterior, and apical components (L, P, and A).
Mitral Annular Geometry
The septal-lateral diameter of the annulus was calculated as the distance in 3-dimensional space between the 2 markers placed in the middle of the septal and lateral mitral annulus, respectively (#0 and 4, Figure 1). The commissure-commissure diameter was calculated as the distance between the 2 annular commissural markers (#2 and 6, Figure 1).
Statistical Analysis
All of the data are reported as mean 1 SD. Changes in the CIMR(+) and CIMR(-) groups from baseline to chronic were analyzed using Students t test for paired comparisons. Changes from baseline to chronic conditions between the CIMR(+) and CIMR(-) groups were compared using a t test for unpaired comparisons.
| Results |
|---|
|
|
|---|
|
Table 2 and Figures 2 and 3 summarize mitral annular dimensions at end-systole. Both groups developed annular dilatation, with the increase in septal-lateral dimension being greater in the CIMR(+) group than in the CIMR(-) group (4.9±2.7 versus 2.3±2.0, P=0.02). The amount of commissure-commissure annular dilatation after inferior MI was not statistically different between the 2 groups.
|
|
|
Table 2, and Figures 2 and 3 summarize papillary muscle displacements after infarction. The increase in total distance from the posterior papillary muscle tip to the fibrosa was greater in the CIMR(+) animals than in the CIMR(-) animals (6.5±3.2 versus 3.1±2.7, P=0.02), and was associated with greater lateral displacement of the posterior papillary muscle (PPM; 6.8±3.4 versus 2.5±3.5 mm, P=0.01). In both groups, the anterior papillary muscle moved toward the apex, and the PPM was displaced toward the annulus in the left ventricular long axis dimension.
Table 3, and Figures 2 and 3 present anterior and posterior mitral leaflet positions at end-systole before and after chronic infarction. No significant changes in anterior leaflet edge position were noted in the CIMR(-) group. In the CIMR(+) hearts, the anterior leaflet moved 2.5±1.8 mm laterally, but the posterior leaflet moved 4.4±3.2 laterally, 1.2±1.5 mm posteriorly, and 1.7±1.0 apically. In addition, the apical displacement of the posterior leaflet was significantly greater than the change in the CIMR(-) hearts (1.7±1.0 versus 0.3±0.5, P=0.01).
|
| Discussion |
|---|
|
|
|---|
The results of this experiment resemble the clinical situation where only some patients develop CIMR after inferior MI. The surgically-created infarction caused similar and substantial hemodynamic and geometric perturbations in both groups, but those in the CIMR(-) hearts were not sufficient to produce CIMR. By comparing the changes in the animals that developed CIMR with the changes in those that did not, we could examine which specific distortions render the valve incompetent after chronic infarction.
Annular Geometry
Chronic infarction caused marked increases in mitral annular dimensions in both groups, with the increase in septal-lateral dimension being significantly greater in animals with CIMR. Septal-lateral diameter is often implicated in leaflet malcoaptation in acute ischemic MR and functional MR or CIMR,12,13 whereas the mechanistic importance of commissure-to-commissure annular dilatation has been debated.14 Green et al used topical phenol to create mitral annular dilation in the commissure-commissure (but not septal-lateral) direction without MR. Commissure-commissure annular dilatation was similar in the CIMR(+) and CIMR(-) animals, suggesting that remodeling in this dimension is not sufficient to produce functional MR. These increases in annular dimensions require the mitral leaflets to cover more area, exhausting the normal excess "reserve" of leaflet tissue, which is additionally compounded by less effective leaflet closure because of apical tethering or tenting of the leaflets.
Papillary Muscle Geometry
Previous clinical1517 and experimental8,18,19 studies have described the role of papillary muscle displacement in the development in CIMR. Other investigators have used echocardiography to link both total and laterally-directed papillary muscle displacement to apical restriction of the mitral leaflets.17,20 This study is the first to characterize fully the 3-dimensional geometry of the papillary muscles in the setting of CIMR, which might be expected to produce greater remodeling of the subvalvular apparatus. This enables the determination of not only how much, but in which direction each papillary muscle was displaced after MI. In the present study, infarction caused the posterior papillary muscle to move posteriorly and "upwards" toward the annulus in both groups, whereas a 6.8 mm lateral displacement of the posterior papillary muscle only in the CIMR(+) hearts accounted for a 7-mm increase in total PPM displacement from the fibrosa. The upward movement of the PPM in the long axis, a previously unreported finding, is consistent with previous studies of acute ischemic MR,7,21 and paradoxically should theoretically tend to relieve apical tenting of the mitral leaflets. This displacement of the posterior papillary muscle tip closer to the annulus probably results from both a failure of the ischemic posterior papillary muscle to contract during systole (as described by Messas et al22) and lengthening of the infarcted papillary muscle over time. However, the posterior and lateral movement of the posterior papillary muscle was great enough to cause net total posterior papillary muscle displacement resulting in apical leaflet restriction. As PPM displacement in the apical and posterior directions was similar in both groups, we believe that the additional lateral PPM displacement, which was significantly greater in the CIMR(+) hearts than the CIMR(-) hearts (6.8±3.4 versus 2.5±3.5 mm, P=0.01), was a dominant factor in the development of CIMR after inferior myocardial infarction in this model, as shown in Figure 3.
The nonischemic anterior papillary muscle may also play a role in apical leaflet restriction.6,17,21 In this study, the normally shortening anterior papillary muscle was apically displaced at end-systole relative to baseline in both the CIMR(+) and CIMR(-) groups.
Leaflet Geometry
Consistent with the 3-dimensional displacements of the papillary muscles, CIMR was associated with apical restriction of the posterior leaflet, which was not seen in the CIMR(-) group. Such apical displacement of the leaflet (Carpentier type IIIb restricted systolic leaflet motion) prevents effective valve closure.21 Leaflet restriction, measured echocardiographically as apical displacement of the point of coaptation of both mitral leaflets, correlated with posterior and lateral papillary muscle displacement,17,20 but the present findings underscore the importance of examining alterations in 3-dimensional papillary muscle geometry as a mechanism of CIMR. In the present experiment, which uniquely allowed independent assessment of the position of each leaflet edge, the anterior leaflet was not displaced apically after infarction, although with more time and additional remodeling (beyond 7 weeks), apical restriction of the anterior leaflet (AL) might occur. CIMR was also associated with posterior leaflet displacement in the posterior direction, and lateral displacement of both leaflets. In an ovine model of acute IMR, Lai et al demonstrated similar lateral displacement of the central scallop of the posterior leaflet, suggesting that inter-scallop malcoaptation could be a mechanism of MR.23 The CIMR(-) animals did not have any changes in end-systolic leaflet position after inferior myocardial infarction.
| Summary |
|---|
|
|
|---|
Study Limitations
This study used a model of ovine chronic inferior infarction that differs from the clinical entity in some respects. The sheep have all undergone opening of the pericardium, cardiopulmonary bypass, and surgical manipulation of the mitral apparatus. Also, differences in leaflet, annular, papillary muscle, and coronary anatomy between sheep and humans may influence the anatomical remodeling in chronic infarction and the distortions required to develop CIMR.
Baseline differences between the CIMR(+) and CIMR(-) groups might account for the development of CIMR in some sheep but not in others. However, no significant differences in baseline geometry or hemodynamics were demonstrable between the 2 groups. Furthermore, comparison of the geometric changes in the 2 groups after normalization for body surface area and baseline EDV yielded significant differences only in the same parameters as the initial analysis. Furthermore, the CIMR(+) and CIMR(-) groups were not different with respect to infarct location or the number of vessels ligated. A more detailed analysis to identify why CIMR develops in some animals but not others is currently underway in additional animals.
Quantitative measures of MR, such as estimated regurgitant orifice and regurgitant volume, have shown promise in studies of CIMR.17,20 In this experiment, severity of MR was graded semiquantitatively and subjectively by jet size on a scale of 0 to 4+ (a standard method used in clinical practice) by the same echocardiographer (DL). Increased separation between the esophagus and the heart in sheep relative to humans resulted in variable echocardiographic image quality, precluding the calculation of more quantitative measures of MR.
Leaflet geometry in this study was characterized by markers placed on the central free edges of the anterior and posterior mitral leaflets. Displacement in other areas of the leaflets (ie, near the commissures) may also play a role in leaflet malcoaptation. Additional studies in this model of chronic infarction using a denser leaflet marker array are currently underway.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Tahta SA, Oury JH, Maxwell JM, et al. Outcome after mitral valve repair for functional ischemic mitral regurgitation. J Heart Valve Dis. 2002; 11: 1118.[Medline] [Order article via Infotrieve]
3. Cohn LH, Rizzo RJ, Adams DH, et al. The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement. Eur J Cardiothorac Surg. 1995; 9: 568574.[Abstract]
4. Czer LS, Maurer G, Trento A, et al. Comparative efficacy of ring and suture annuloplasty for ischemic mitral regurgitation. Circulation. 1992; 86 (5 Suppl): II46-II52.
5. Hausmann H, Siniawski H, Hetzer R. Mitral valve reconstruction and replacement for ischemic mitral insufficiency: seven years follow up. J Heart Valve Dis. 1999; 8: 536542.[Medline] [Order article via Infotrieve]
6. Liel-Cohen N, Guerrero JL, Otsuji Y, et al. Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: insights from 3-dimensional echocardiography. Circulation. 2000; 101: 27562763.
7. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation. 2001; 104: 19581963.
8. Llaneras MR, Nance ML, et al. Large animal model of ischemic mitral regurgitation. Ann Thorac Surg. 1994; 57: 432439.[Abstract]
9. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1987; 75: 175183.
10. Niczyporuk MA, Miller DC. Automatic tracking and digitization of multiple radiopaque myocardial markers. Comput Biomed Re.s. 1991; 24: 129142.[CrossRef][Medline] [Order article via Infotrieve]
11. Moon MR, DeAnda A, Jr., Daughters GT, et al. Experimental evaluation of different chordal preservation methods during mitral valve replacement. Ann Thorac Surg. 1994; 58: 931943.[Abstract]
12. Timek T, Glasson JR, Dagum P, et al. Ring annuloplasty prevents delayed leaflet coaptation and mitral regurgitation during acute left ventricular ischemia. J Thorac Cardiovasc Surg. 2000; 119(4 Pt 1): 774783.
13. Glasson JR, Komeda M, Daughters GT, et al. Early systolic mitral leaflet "loitering" during acute ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 1998; 116: 193205.
14. Green GR, Dagum P, Glasson JR, et al. Mitral annular dilatation and papillary muscle dislocation without mitral regurgitation in sheep. Circulation. 1999; 100 (19 Suppl): II95102.
15. Burch GE, DePasquale N, Phillips JH. The papillary muscle syndrome. JAMA. 1968; 204: 249252.
16. Godley RW, Wann LS, Rogers EW, et al. Incomplete mitral leaflet closure in patients with papillary muscle dysfunction. Circulation. 1981; 63: 565571.
17. Yiu SF, Enriquez-Sarano M, Tribouilloy C, et al. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study. Circulation. 2000; 102: 14001406.
18. Gorman JH, III, Gorman RC, Plappert T, et al. Infarct size and location determine development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg. 1998; 115: 615622.
19. Gorman JH, III, Jackson BM, Gorman RC, et al. Papillary muscle discoordination rather than increased annular area facilitates mitral regurgitation after acute posterior myocardial infarction. Circulation. 1997; 96 (9 Suppl): II-7.
20. Otsuji Y, Handschumacher MD, Liel-Cohen N, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol. 2001; 37: 641648.
21. Lai DT, Timek TA, Dagum P, et al. The effects of ring annuloplasty on mitral leaflet geometry during acute left ventricular ischemia. J Thorac Cardiovasc Surg. 2000; 120: 966975.
22. Messas E, Guerrero JL, Handschumacher MD, et al. Paradoxic decrease in ischemic mitral regurgitation with papillary muscle dysfunction: insights from three-dimensional and contrast echocardiography with strain rate measurement. Circulation. 2001; 104: 19521957.
23. Lai DT, Tibayan FA, Myrmel T, et al. Mechanistic insights into posterior mitral leaflet inter-scallop malcoaptation during acute ischemic mitral regurgitation. Circulation. 2002; 106 (12 Suppl 1): I40I45.
This article has been cited by other articles:
![]() |
M. V. Badiwala, S. Verma, and V. Rao Surgical Management of Ischemic Mitral Regurgitation Circulation, September 29, 2009; 120(13): 1287 - 1293. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |